Hologic has announced the US launch of its new Fluent fluid management system, featuring innovations designed to provide operating room (OR) staff more simplified and effective fluid management for hysteroscopic procedures. "Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology," said Edward Evantash, M.D., Medical Director and Vice President of Global Medical Affairs, Hologi...

Hologic's Cynosure division has announced the launch of TempSure Envi – an FDA-cleared advanced radiofrequency device that minimises facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite. TempSure Envi is a simpler way for patients to maintain beautiful skin. The device heats the deep layers of skin to regenerate collagen and improve the appearance of cellulite and wrink...

Hologic, Inc. has announced today the U.S. launch of the MyoSure MANUAL device, which was designed to help doctors more easily resect and remove intrauterine tissue in office settings when used with the MyoSure hysteroscope. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products. The complete MyoSure system is a minimally invasive hysteroscopic treatment for women with problematic tissue that requires no caut...

  Hologic has announced the commercial availability of its new SmartCurve breast stabilisation system, which has been clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose.

Hologic has announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging technology, a real-time breast biopsy and verification system that enhances workflow, improves the patient experience and streamlines the entire biopsy process from start to finish. The first-of-its-kind Brevera system is designed to increase biopsy accuracy with real-time imaging that delivers valuable information at the point ...

  Hologic has announced that the Genius 3D Mammography exam is now the only mammogram that is FDA-approved as superior to standard 2D mammography for routine breast cancer screening of women with dense breasts.